UbiQ-114

K63 diUb PA

details

K63 diUb PA (UbiQ-114) is a potent, irreversible and specific inhibitor based on K63 linked diUb that targets the S2 pocket of deubiquitinating enzymes (DUBs). The C-terminus of the proximal Ub is equiped with the propargylamide (PA) electrophile and the isopeptide bond between the two Ub proteins is replaced by a DUB resistant mimic.

This DUB activity based probe can be used for activity profiling experiments and structural studies. Please note the native distance between the proximal and distal Ub is preserved as much as possible. UbiQ-114 has been prepared by total chemical synthesis.

Product Attachments

UbiQ-114 Productsheet B01082015-001 Size: (240.31 KB)

crystallizationpull downpurificationwestern blotphenotypic protein profiling

Qty Available: 0

€300.00

aliquot size

€300.00

| Add to Compare

name	K63 diUb PA
product code	UbiQ-114
Applications	crystallization, pull down, purification, western blot, phenotypic protein profiling
target	DUB
source	human sequence, synthetic
shipping	solution
purity	≥90% by RP-HPLC and SDS-PAGE analysis
molecular weight	17.1 kDa by MS
storage	upon arrival powder at −20°C, solution at −80°C.
sample preparation	For detailed sample preparation see product sheet.
regulatory statement	For laboratory research use only, not for use in humans.

Galardy et al.
Galardy, P., et al. Mechanism-based proteomics tools based on ubiquitin and ubiquitin-like proteins: crystallography, activity profiling, and protease identification. Methods in Enzymology. 399, 120-131 (2005).

http://www.ncbi.nlm.nih.gov/pubmed/16338352
Ekkebus et al.
Ekkebus, R., et al. On terminal alkynes that can react with active-site cysteine nucleophiles in proteases. J. Am. Chem. Soc. 135, 2867-2870 (2013).

http://www.ncbi.nlm.nih.gov/pubmed/23387960

UbiQ-Probes crystallization overview download this pdf
UbiQ_DUB Probes factsheet download this pdf
UbiQ's drug discovery expertise overview

download this pdf